For children exposed in utero to cyclosporine such an effect has not been described. The results of this survey show that this drug does not induce birth defects. Although the drug crosses the placental barrier there is no evidence of a direct hazard to the fetus. However there is an increased incidence of complications in mothers and babies which apparently results from organ transplantation. Therefore, female transplant recipients wishing to conceive should be informed of these risks.
Bibliography is available.